Compared with untargeted micelles that showed passive tumor targeting capability only, anti-EpCAM-conjugated micelles had active and passive targeting capabilities, resulting in a higher tumor aggregation rate of micelles in tumors even after 48 h. The gene discussed is EPCAM; the disease is neoplasm.